Clinical trial
Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant…
NCT00152984 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00152984 |
|---|---|
| Title | Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma |
| Official title | A 12-week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18μg q.d. in Patients With COPD and a Concomitant Diagnosis of Asthma |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, Asthma |
| Intervention type | Drug |
| Interventions | Tiotropium inhalation capsules, Placebo inhalation capsules |
| Enrollment | 472 |
| Start date | Dec 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, South Africa |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: